Certified by Founder
Lodge
Breega
investor
France
- Paris
- 23/06/2022
- Series A
- $254,000,000
Breega propels pioneering and purpose-driven founders from idea into impact. We closed our first fund in 2015 and now have €500 m AUM and 70 trailblazing portfolio companies. Crafted for founders by founders, we built Breega to provide start-ups with the help we wish we'd had. And we’ve created an investment proposition that’s purposefully designed. We call it full stack funding: providing capital and connections, expertise and experience, support and solidarity for entrepreneurs at every step of their journey. We invest across Europe and internationally, focusing on pre-seed to Series B stage.
- Industry Venture Capital & Private Equity
- Website https://www.breega.com/
- LinkedIn https://www.linkedin.com/company/breega/
Juvena Therapeutics | $33,500,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
Allos | $5,000,000 | (Jan 14, 2026)
PayMedix | $33,000,000 | (Jan 14, 2026)
WeatherPromise | $12,800,000 | (Jan 14, 2026)
Diffraqtion | $4,200,000 | (Jan 14, 2026)
WithCoverage | $42,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
Cloudforce | $10,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)